XSPA - XpresSpa expands its footprint in health wellness services beyond COVID-19 testing; shares up 5%

XpresSpa (XSPA) says it has expanded its testing services beyond COVID-19, to offer additional rapid testing services for other communicable diseases that include influenza, mononucleosis and group A streptococcus under XpresCheck, supporting the health and wellbeing of airport and airlines employees and the traveling public.XpresCheck is offering the season’s 2020/21 flu vaccination as well as a quadrivalent high-dose flu vaccine, approved for seniors.The current COVID-19 tests includes the rapid molecular COVID-19 test Polymerase Chain Reaction ((or PCR)) Test and Blood Antibody Test, available to all airport employees, including airline employees, contractors and workers, concessionaires and their employees, TSA officers, and U.S. Customs and Border Protection agents, as well as airline passengers.Shares up 4.6% PM.

For further details see:

XpresSpa expands its footprint in health, wellness services beyond COVID-19 testing; shares up 5%